Technology | October 02, 2012

VirtuoSaph Plus Endoscopic Vessel Harvesting System from Terumo Provides Cardiac Surgery Team with Control, Consistency and Confidence

Terumo continues the advancement of the minimally invasive technique for coronary and peripheral artery bypass grafting.

Terumo VirtuoSaph Plus Endoscopic Vessel Harvesting System

October 2, 2012 — Terumo Cardiovascular Systems has announced the introduction of the VirtuoSaph Plus Endoscopic Vessel Harvesting System following clearance by the U.S. Food and Drug Administration (FDA).

The VirtuoSaph Plus system provides an endoscopic approach to vessel harvesting, and is used for coronary artery and peripheral artery bypass graft procedures. The system offers the cardiac surgery team a device that, when used in conjunction with the 'Terumo Method' of vessel harvesting, consistently delivers bypass grafts with a new standard of care.  The Terumo Method, developed by Terumo's team of engineers and dedicated clinical specialists, is a comprehensive set of guidelines designed to aid vessel harvesters in their pursuit of consistently high conduit quality.

Proven features retained from the original VirtuoSaph system include a completely integrated design, open CO2 insufflation and one step sealing and cutting capabilities.  Key new features of the VirtuoSaph Plus system include:

  • Improved recyclable packaging features tray-in-tray design, offering easy access to the sterile tray and an ergonomic grip for better circulation of device
  • Patented PTFE dissector rod, designed to reduce the force required to create a tunnel and now with extended working length, allowing dissection of longer vessels
  • Precise control of spot cautery, with a safety switch available when needed
  • First of its kind integrated bipolar cord, minimizing the number of connections and improving electrical conductivity
  • Unique endoscope wiper now available on an all access 360 degree ring switch

"We find that use of the VirtuoSaph Plus system has given us an enhanced feeling of control. The longer PTFE dissector rod requires the use of less force and has reduced resistance during dissection.   We also value the time that Terumo's Clinical Specialists devoted to us and our CVOR team as we learned about the capabilities of this impressive new product," said Timothy McCoy, PA-C, at The Toledo Hospital.  He added, "Since we began using the VirtuoSaph Plus system we feel more confident that our team is providing our patients with high quality conduits that offer the patency our patients require for a positive outcome."

Michael Moront, M.D., also at The Toledo Hospital, agrees, adding "The improved ergonomics and well-engineered new design of the VirtuoSaph Plus system will result in improved conduit quality and better outcomes for our patients."

For more information:



Related Content

Bilateral Artery Use Does Not Improve 10-Year CABG Outcomes
News | Cardiovascular Surgery | September 06, 2018
While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary...
Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery | May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Scientists Show How Cells React to Injury From Open-Heart Surgery
News | Cardiovascular Surgery | May 04, 2017
Cedars-Sinai Heart Institute investigators have learned how cardiac muscle cells react to a certain type of injury that...
ERACS Session Highlights Need for Standardized Best Practices in Cardiac Surgery
News | Cardiovascular Surgery | May 02, 2017
The recently formed group Enhanced Recovery After Cardiac Surgery (ERACS) hosted an organizing session in Boston on...
ClearFlow Receives Frost & Sullivan New Product Innovation Award for PleuraFlow Technology
News | Cardiovascular Surgery | May 01, 2017
ClearFlow Inc. has received the prestigious 2017 Global Frost & Sullivan Award for New Product Innovation. The...
Overlay Init